X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26) 26
index medicus (23) 23
male (20) 20
female (19) 19
aged (17) 17
hematology (16) 16
middle aged (16) 16
oncology (16) 16
adult (15) 15
chemotherapy (12) 12
rituximab (11) 11
transplantation (10) 10
treatment outcome (10) 10
article (9) 9
hemic and lymphatic diseases (9) 9
patients (8) 8
drug therapy (7) 7
lymphomas (7) 7
analysis (6) 6
clinical trials (6) 6
cyclophosphamide (6) 6
disease-free survival (6) 6
fludarabine (6) 6
hematology, oncology and palliative medicine (6) 6
leukemia, lymphocytic, chronic, b-cell - drug therapy (6) 6
lymphoma (6) 6
neutropenia (6) 6
stem cells (6) 6
young adult (6) 6
abridged index medicus (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
cancer (5) 5
immune system diseases (5) 5
immunohistochemistry (5) 5
immunotherapy (5) 5
leukemia (5) 5
recurrence (5) 5
research (5) 5
survival rate (5) 5
therapy (5) 5
antineoplastic agents - adverse effects (4) 4
antineoplastic agents - therapeutic use (4) 4
b-cell lymphoma (4) 4
brentuximab vedotin (4) 4
care and treatment (4) 4
cytokines (4) 4
diagnosis (4) 4
dosage and administration (4) 4
hodgkin lymphoma (4) 4
immunology (4) 4
lymphocytes (4) 4
lymphocytes b (4) 4
lymphoma, non-hodgkin - immunology (4) 4
medical prognosis (4) 4
monoclonal antibodies (4) 4
non-hodgkin's lymphomas (4) 4
outcomes (4) 4
phase-ii (4) 4
retrospective studies (4) 4
stem cell transplantation (4) 4
aged, 80 and over (3) 3
allogeneic transplantation (3) 3
antibody-drug conjugate (3) 3
biomarkers (3) 3
cd19 antigen (3) 3
cell count (3) 3
chronic lymphocytic leukemia (3) 3
comorbidity (3) 3
complications and side effects (3) 3
drug therapy, combination (3) 3
genetic aspects (3) 3
hematopoietic stem cell transplantation (3) 3
hematopoietic stem cell transplantation - methods (3) 3
hematopoietic stem cells (3) 3
idelalisib (3) 3
immunochemotherapy (3) 3
immunoconjugates - adverse effects (3) 3
immunoconjugates - therapeutic use (3) 3
immunotherapy, adoptive - methods (3) 3
leukemia, lymphocytic, chronic, b-cell - mortality (3) 3
lymphocytes t (3) 3
lymphoma, large b-cell, diffuse - therapy (3) 3
lymphoma, non-hodgkin - drug therapy (3) 3
lymphoma, non-hodgkin - therapy (3) 3
malignancies (3) 3
mutation (3) 3
nausea (3) 3
neoplasm staging (3) 3
open-label (3) 3
pyrazoles - therapeutic use (3) 3
pyrimidines - therapeutic use (3) 3
safety (3) 3
survival (3) 3
survival analysis (3) 3
t-lymphocytes - immunology (3) 3
t-lymphocytes - metabolism (3) 3
transplantation, autologous (3) 3
trial (3) 3
tumors (3) 3
abstracts (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2017, Volume 377, Issue 26, pp. 2531 - 2544
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 25, pp. 2425 - 2437
Journal Article
Molecular Therapy, ISSN 1525-0016, 01/2017, Volume 25, Issue 1, pp. 285 - 295
Outcomes for patients with refractory diffuse large B cell lymphoma (DLBCL) are poor. In the multicenter ZUMA-1 phase 1 study, we evaluated KTE-C19, an... 
refractory NHL | diffuse large B cell lymphoma | CAR T | CD19 | KTE-C19 | MEDICINE, RESEARCH & EXPERIMENTAL | CD8(+) | MANAGEMENT | SUBSETS | CHEMOTHERAPY | TRANSPLANTATION | MALIGNANCY | B-CELL | REMISSIONS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | BLINATUMOMAB | OUTCOMES | Lymphoma, Non-Hodgkin - immunology | Follow-Up Studies | Humans | Middle Aged | Receptor-CD3 Complex, Antigen, T-Cell - genetics | Drug Resistance, Neoplasm | Male | Recombinant Fusion Proteins | CD28 Antigens - metabolism | Receptor-CD3 Complex, Antigen, T-Cell - metabolism | Lymphoma, Large B-Cell, Diffuse - therapy | CD28 Antigens - genetics | T-Lymphocytes - metabolism | Lymphoma, Large B-Cell, Diffuse - immunology | Adult | Female | Antigens, CD19 - immunology | Immunotherapy, Adoptive - adverse effects | Immunotherapy, Adoptive - methods | Immunophenotyping | Treatment Outcome | Combined Modality Therapy | Disease Progression | Lymphoma, Large B-Cell, Diffuse - diagnosis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, Non-Hodgkin - therapy | Biomarkers | T-Lymphocytes - immunology | Aged | Neoplasm Staging | Lymphoma, Non-Hodgkin - diagnosis | Delirium | Cardiac arrhythmia | CD19 antigen | Kidneys | Cytokines | Lymphocytes T | Metabolism | CD28 antigen | Patients | Neurotoxicity | Cyclophosphamide | Chemotherapy | Fludarabine | Lymphocytes B | Lymphocytes | Response rates | Sepsis | Hypoxia | Lymphomas | Neutropenia | B-cell lymphoma | Original
Journal Article
The Lancet Oncology, ISSN 1470-2045, 01/2019, Volume 20, Issue 1, pp. 31 - 42
Axicabtagene ciloleucel is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. In the previous analysis of the ZUMA-1 registrational study,... 
2-YEAR SURVIVORS | HODGKIN | CHIMERIC ANTIGEN RECEPTOR | OUTCOMES | ONCOLOGY | TRANSPLANTATION | Analysis | Lymphomas
Journal Article
ONCOLOGY (United States), ISSN 0890-9091, 03/2015, Volume 29, Issue 3
Journal Article
Hematology, ISSN 1520-4391, 12/2012, Volume 2012, Issue 1, pp. 246 - 250
Abstract A 63-year-old male patient without siblings is treated for acute myeloid leukemia with poor prognostic cytogenetics. Despite achieving a first... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2017, Volume 35, Issue 1, pp. 24 - 31
Journal Article
by Ghinda, Diana and Chen, Suzan and Bedaiwy, Mahmoud and Jabri, Hussam and Alshardan, Mohammad and Taccone, Michael S and Lai, Carolyn and Rabski, Jessica and Tsai, Eve and Dedek, Annemarie and Xu, Jian and Tsai, Eve and Lombroso, Paul and Hildebrand, Mike and Mothe, Andrea and Tator, Charles H and Siladi, Andrew and Nally, Jaqueline and Stirling, David and Keller, Anastasia and Buckley, Christian and Shum-Siu, Alice and Magnuson, David and Rosenbaum, Benjamin P and Kelly, Michael L and Ahuja, Christopher and Ahuja, Christopher and Nori, Satoshi and Khazaei, Mohamad and Ahlfors, Jan-Eric and Liu, Yang and Wang, Jian and Fuehrmann, Tobias and Pakulska, Malgosia and Hettiaratchi, Marian H and Poon, Peter and Shoichet, Molly S and Fehlings, Michael G and Fehlings, Michael G and Fehlings, Michael G and Hazrati, Lili-Naz and Cherian, Leela and Nilewski, Lizanne and Tour, James M and Kent, Thomas A and Robertson, Claudia S and Wilde, Elisabeth and Newsome, Mary and Scheibel, Randall and Troyanskaya, Maya and Velez, Carmen and Wade, Benjamin and Drennon, Ann Marie and York, Gerald and Bigler, Erin and Abildskov, Tracy and Taylor, Brian and Jaramillo, Carlos and Eapen, Blessen and Belanger, Heather and Morey, Rajendra and Haswell, Courtney and Levin, Harvey and Hinds, Sidney and Walker, William and Walker, William and Kochunov, Peter and Jahanshad, Neda and Thompson, Paul and Tate, David and Statz, Jonathan and Goodrich, Jessica and Goforth, Cdr Carl and Tschiffely, Anna E and Arena, John D and Smith, Douglas H and Wolf, John A and Johnson, Victoria E and Rhodes, James and Friess, Stuart and Lee, Taylor and Lycke, Roy J and Jang, Ikbeom and Vike, Nicole L and Nauman, Eric A and Talavage, Thomas M and Rispoli, Joseph V and Alonso-Escalante, Jose and Fulton, William and Sodhi, Chhinder and Hackam, David J and Nasr, Isam W and Hubbard, W B and Joseph, Binoy and Spry, Malinda L and Vekaria, Hemendra J and Saatman, Kathryn and Sullivan, Patrick G and Sullivan, Patrick G and Vascak, Michal and ...
Journal of Neurotrauma, ISSN 0897-7151, 08/2018, Volume 35, Issue 16, pp. A-1 - A-285
[...]the vast majority of basic science pain research ends at target identification and validation in rodent models of chronic pain without confirmation in... 
Abstracts | Neurosciences | Keywords | Traumatic brain injury | Cytokines | Central nervous system | Inflammation | Gene expression | Trauma | Studies | Brain research | Hospitals | Pain | Rodents | Stem cells | DNA methylation | Biomarkers | Spinal cord injuries | Growth factors | Research centers | Proteins
Journal Article
Leukemia, ISSN 0887-6924, 08/2018, Volume 32, Issue 8, pp. 1768 - 1777
Journal Article